Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia.

Yusoff FM, Kajikawa M, Matsui S, Hashimoto H, Kishimoto S, Maruhashi T, Chowdhury M, Noma K, Nakashima A, Kihara Y, Sueda T, Higashi Y.

Sci Rep. 2019 May 22;9(1):7711. doi: 10.1038/s41598-019-44176-5.

2.

Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.

Abdul Wahid SF, Ismail NA, Wan Jamaludin WF, Muhamad NA, Abdul Hamid MKA, Harunarashid H, Lai NM.

Cochrane Database Syst Rev. 2018 Aug 29;8:CD010747. doi: 10.1002/14651858.CD010747.pub2.

PMID:
30155883
3.

Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.

Wahid FSA, Ismail NA, Wan Jamaludin WF, Muhamad NA, Mohamad Idris MA, Lai NM.

Curr Stem Cell Res Ther. 2018;13(4):265-283. doi: 10.2174/1574888X13666180313141416. Review.

PMID:
29532760
4.

Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan.

Kondo K, Yanishi K, Hayashida R, Shintani S, Shibata R, Murotani K, Ando M, Mizuno M, Fujiwara T, Murohara T, Matoba S; TACT Follow-up Study Investigators.

Circ J. 2018 Mar 23;82(4):1168-1178. doi: 10.1253/circj.CJ-17-0510. Epub 2018 Jan 30.

5.

Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.

Idei N, Soga J, Hata T, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Nishioka K, Hidaka T, Kihara Y, Chowdhury M, Noma K, Taguchi A, Chayama K, Sueda T, Higashi Y.

Circ Cardiovasc Interv. 2011 Feb 1;4(1):15-25. doi: 10.1161/CIRCINTERVENTIONS.110.955724. Epub 2011 Jan 4.

PMID:
21205941
6.

Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.

Franz RW, Parks A, Shah KJ, Hankins T, Hartman JF, Wright ML.

J Vasc Surg. 2009 Dec;50(6):1378-90. doi: 10.1016/j.jvs.2009.07.113. Epub 2009 Oct 17.

7.
8.

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma - Subanalysis of the Long-Term Clinical Outcomes Survey.

Shoji K, Yanishi K, Yoshimi R, Hamada N, Kondo K, Fujimoto K, Nakajima H, Kuwahara K, Higashi Y, Fukumoto Y, Murohara T, Matoba S; TACT Follow up Study Investigators.

Circ J. 2019 Feb 25;83(3):662-671. doi: 10.1253/circj.CJ-18-1044. Epub 2019 Feb 7.

9.

Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.

Malyar NM, Radtke S, Malyar K, Arjumand J, Horn PA, Kröger K, Freisinger E, Reinecke H, Giebel B, Brock FE.

Cytotherapy. 2014 Sep;16(9):1270-9. doi: 10.1016/j.jcyt.2014.05.001. Epub 2014 Jun 24.

PMID:
24972744
10.

[A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].

Gu Y, Zhang J, Qi L.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Oct;20(10):1017-20. Chinese.

PMID:
17140078
11.

Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.

Subrammaniyan R, Amalorpavanathan J, Shankar R, Rajkumar M, Baskar S, Manjunath SR, Senthilkumar R, Murugan P, Srinivasan VR, Abraham S.

Cytotherapy. 2011 Sep;13(8):993-9. doi: 10.3109/14653249.2011.579961. Epub 2011 Jun 15.

PMID:
21671823
12.

Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.

Zafarghandi MR, Ravari H, Aghdami N, Namiri M, Moazzami K, Taghiabadi E, Fazel A, Pournasr B, Farrokhi A, Sharifian RA, Salimi J, Moini M, Baharvand H.

Cytotherapy. 2010 Oct;12(6):783-91. doi: 10.3109/14653240903518163.

PMID:
20078390
13.

Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.

Madaric J, Klepanec A, Valachovicova M, Mistrik M, Bucova M, Olejarova I, Necpal R, Madaricova T, Paulis L, Vulev I.

Stem Cell Res Ther. 2016 Aug 17;7(1):116. doi: 10.1186/s13287-016-0379-z.

14.

Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia.

Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K, Oshima T, Chayama K, Sueda T, Goto C, Matsubara H, Murohara T, Yoshizumi M.

Circulation. 2004 Mar 16;109(10):1215-8. Epub 2004 Mar 8.

PMID:
15007007
15.

Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.

Aoyama N, Nishinari M, Ohtani S, Kanai A, Noda C, Hirata M, Miyamoto A, Watanabe M, Minamino T, Izumi T, Ako J.

Heart Vessels. 2017 Sep;32(9):1099-1108. doi: 10.1007/s00380-017-0968-5. Epub 2017 Mar 29.

PMID:
28357515
16.

Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.

Moazzami K, Majdzadeh R, Nedjat S.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD008347. doi: 10.1002/14651858.CD008347.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;12:CD008347.

PMID:
22161427
17.

Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.

Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC.

Ann Surg. 2013 Dec;258(6):922-9. doi: 10.1097/SLA.0b013e3182854cf1.

PMID:
23426345
18.

The prostacyclin analog beraprost sodium augments the efficacy of therapeutic angiogenesis induced by autologous bone marrow cells.

Otsuka H, Akashi H, Murohara T, Okazaki T, Shintani S, Tayama K, Sasaki K, Imaizumi T, Aoyagi S.

Ann Vasc Surg. 2006 Sep;20(5):646-52. Epub 2006 Jul 18.

PMID:
16847717
19.
20.

Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia.

Smadja DM, Duong-van-Huyen JP, Dal Cortivo L, Blanchard A, Bruneval P, Emmerich J, Gaussem P.

Cytotherapy. 2012 Feb;14(2):232-9. doi: 10.3109/14653249.2011.627917. Epub 2011 Oct 31.

PMID:
22040109

Supplemental Content

Support Center